NR4A1 and breast carcinoma: CDIM8 also antagonizes one or more NR4A1-regulated pro-oncogenic pathways or genes in several different breast cancer cell lines including HS578T, SUM159, MDA-MB-231, SKBR3, 4T1 (mouse), and MCF-7 cells [20,21,22,23,24].